Syngene InternationalNSE:SYNGENE -1.75%82 Median PS Value is ₹784.23 as of Jul. 07, 2026, which is 100% below its 10-year median of 0.72. GuruFocus rates NSE:SYNGENE with a GF Score™ of 82/100 and a GF Value™ of ₹768.19 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 88 Medical Diagnostics & Research companies, Syngene International ranks better than 77.27% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Syngene International's Median PS Value or its related term are showing as below:
NSE:SYNGENE'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.5 Med: 0.72 Max: 0.94
Current: 0.54
During the past 13 years, the highest Price to Median PS Value of Syngene International was 0.94. The lowest was 0.50. And the median was 0.72.
NSE:SYNGENE's Price-to-Median-PS-Value is ranked better than 77.27% of 88
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.9
vs NSE:SYNGENE: 0.54
Syngene International (NSE:SYNGENE) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Syngene International's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
422.70
/
784.23
=
0.54
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syngene International Median PS Value Related Terms
Syngene International Median PS Value Historical Data
* Premium members only.
The historical data trend for Syngene International's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SYNGENE vs TMO, DHR, IDXX: Median PS Value Comparison
For the Diagnostics & Research subindustry, Syngene International's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syngene International Price-to-Median-PS-Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Syngene International's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Syngene International's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 8.4607.
Syngene International's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹92.691.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syngene International (NSE:SYNGENE) has a Median PS Value of ₹784.23 as of Jul. 07, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Syngene International and its competitors. This is 108821% above median its historical median of 0.72. Over the past decade, Syngene International's Median PS Value has ranged from 0.50 to 0.94. According to the industry distribution chart, Syngene International ranks #20 out of 88 companies in the Medical Diagnostics & Research industry, placing it in the top 22.7%.
Is Syngene International's Median PS Value too high?
Syngene International's current Median PS Value of ₹784.23 is 108821% above median its 10-year median of 0.72. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 0.94. Based on the distribution chart, Syngene International ranks #20 out of 88 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Syngene International has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngene International's Median PS Value compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Syngene International ranks #20 out of 88 companies for Median PS Value. This places Syngene International in the top 23% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.90. Historically, Syngene International's own Median PS Value has ranged from 0.50 to 0.94 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Diagnostics & Research company?
The median Median PS Value among Medical Diagnostics & Research companies is 0.90, based on 88 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Syngene International and its competitors. For the Medical Diagnostics & Research industry, the median Median PS Value is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syngene International's current Median PS Value is ₹784.23, which is 108821% above median its own 10-year median of 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngene International stock overvalued right now?
Based on GuruFocus' analysis, Syngene International (NSE:SYNGENE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹768.19, compared to a current price of ₹422.70 — trading 45% below its estimated fair value. The current Median PS Value is ₹784.23, which is 108821% above median its 10-year median of 0.72. Syngene International's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Syngene International (NSE:SYNGENE), the current Median PS Value is ₹784.23 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syngene International (NSE:SYNGENE) Overvalued in 2026?
Based on GuruFocus' analysis, Syngene International stock appears to be undervalued.
The current stock price of ₹422.70 is trading 45% below its estimated GF Value™ of ₹768.19.
GuruFocus considers Syngene International to be Significantly Undervalued.
Key valuation signals for NSE:SYNGENE:
Median PS Value: ₹784.23 (108821% above median its 10-year median of 0.72)
GF Value™: ₹768.19 vs. price of ₹422.70 (45% below fair value)
No single metric tells the full story. See the NSE:SYNGENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the USA. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
82GF Score
Get the complete analysis for NSE:SYNGENE
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SYNGENE has been successfully added to your 
